Patients taking one of the drugs leave the pharmacy empty. When the product is back in stock


There is a shortage of medicine consumed by thousands of people in pharmacies. What specificity are we talking about?

 Patients taking one of the drugs leave the pharmacy with a receipt. When the product is available again

As reported by the portal” ABC Zdrowie “, in wholesalers supplying pharmacies with drugs, there is a lack of specificity taken by many patients. The manufacturer of the drug indicates that it will be available soon – from the beginning of August. Get to know the details!

Problems with drug availability

Patients using the hormonal drug Reseligo in a dose of 3.6 mg have been struggling with the problems of its availability since April this year. It was then that the license to trade in the medicine in our country expired. Thanks to the temporary extension of the authorization, the drug went on sale.

Unfortunately, patients who benefit from therapy with this drug are leaving pharmacies with nothing. The manufacturer of the product, the company Zentiva Polska Sp. z o.o. informs that this drug is currently not available for patients. The situation is to change in August this year, when the drug will be released on the market again.

 Patients taking one of the drugs, leave the pharmacy with the receipt. will be available

When using Reseligo

The same drug is still on the market at an increased dose (10.8 mg). Both women and men use the drug. In women, it is used mainly in the treatment of endometriosis – to alleviate the symptoms associated with the disease, as well as in benign tumors of the uterus, breast cancer, and in the treatment of infertility.

In the case of men, the hormonal drug Reseligo is used to treat prostate cancer. Thanks to its use, it is also possible to avoid surgical castration, at least in some cases.

 Patients taking one of the drugs leave the pharmacy with a receipt When the product will be available

Have you encountered a problem with the availability of the drug you are using?


Please enter your comment!
Please enter your name here